Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells

被引:136
作者
Camerer, E [1 ]
Kataoka, H [1 ]
Kahn, M [1 ]
Lease, K [1 ]
Coughlin, SR [1 ]
机构
[1] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M108555200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The coagulation protease Factor Xa (Xa)(1) triggers a variety of cellular responses that may be important for inflammatory reactions to tissue injury. Protease-activated receptors (PAR1, PAR2, and PAR4) can mediate Xa signaling in heterologous expression systems. However, other candidate Xa receptors have been described, and the extent to which one or more PARs account for Xa signaling in relevant differentiated cells is unknown. We examined Xa signaling in endothelial cells from wildtype and PAR-deficient mice. Wild-type endothelial cells responded to agonists for PAR1, PAR2, and PAR4. Relative to wild-type, Xa-triggered phosphoinositide hydrolysis was reduced by 60-75% in Par2 -/- endothelial cells, by 20-30% in Par1 -/- endothelial cells, and by similar to90% in Par2 -/- endothelial cells treated with a PARI antagonist. Similar results were obtained when ERK1/2 phosphorylation was used to assess Xa signaling. Thus PAR2 is the main endogenous Xa receptor in these endothelial cell preparations and, together, PAR2 and PAR1 appear to account for similar to90% of endothelial Xa signaling. By contrast, in fibroblasts, PAR1 by itself accounted for virtually all Xa-induced phosphoinositide hydrolysis. This information is critical for the design and interpretation of knockout mouse studies to probe the possible roles of Xa signaling in vivo.
引用
收藏
页码:16081 / 16087
页数:7
相关论文
共 41 条
[1]
XA RECEPTOR EPR-1 [J].
ALTIERI, DC .
FASEB JOURNAL, 1995, 9 (10) :860-865
[2]
Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]
Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[4]
Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2 [J].
Bono, F ;
Schaeffer, P ;
Hérault, JP ;
Michaux, C ;
Nestor, AL ;
Guillemot, JC ;
Herbert, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) :E107-E112
[5]
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[6]
Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active [J].
Camerer, E ;
Rottingen, JA ;
Iversen, JG ;
Prydz, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29034-29042
[7]
Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene [J].
Camerer, E ;
Rottingen, JA ;
Gjernes, E ;
Larsen, K ;
Skartlien, AH ;
Iversen, JG ;
Prydz, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32225-32233
[8]
Role of the thrombin receptor In development and evidence for a second receptor [J].
Connolly, AJ ;
Ishihara, H ;
Kahn, ML ;
Farese, RV ;
Coughlin, SR .
NATURE, 1996, 381 (6582) :516-519
[9]
Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[10]
TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J].
CREASEY, AA ;
CHANG, ACK ;
FEIGEN, L ;
WUN, TC ;
TAYLOR, FB ;
HINSHAW, LB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2850-2860